a public good project by the
Synthesis
Company
of California

© 2026

Robert S. Kerbel | doi.page

0 works0 citations0 h-index

Robert S. Kerbel

Sunnybrook Health Science Centre(CA)University of Toronto(CA)Sunnybrook Hospital(CA)Sunnybrook Research Institute

Publications by Year

Research Areas

Angiogenesis and VEGF in Cancer, Cancer, Hypoxia, and Metabolism, Cancer Cells and Metastasis, Cancer Treatment and Pharmacology, Cancer Genomics and Diagnostics

Most-Cited Works

→ Angiogenesis as a therapeutic target(2005)2,620 cited
→ Tumor Angiogenesis(2008)1,921 cited
→ Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis(2009)1,697 cited
→ Clinical translation of angiogenesis inhibitors(2002)1,511 cited
→ The anti-angiogenic basis of metronomic chemotherapy(2004)1,393 cited
→ Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity(2000)1,174 cited
→ Establishment and Characterization of First Trimester Human Trophoblast Cells with Extended Lifespan

(1993)

1,056 cited

→ Tumor angiogenesis: past, present and the near future(2000)971 cited

→ β1-6 Branching of Asn-Linked Oligosaccharides Is Directly Associated with Metastasis(1987)938 cited

Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.(1997)